Bioheart Biotechnology is Biotechnology in China that focus on polylactic acid business. Founded in 2014. They cover business area such as developer, absorbable coronary drug-elute stent, specialized coronary drug-elute stent system, rapamycin, racemic polylactic acid, blood vessel, innovative and effective stent vessel system, medical practitioner.
2014
( 10 years old in 2024 )
Polylactic Acid
-
Room 302, 3/F, Building 9
590 Ruiqing Avenue, Zhangjiang High-Tech East Zone, Pudong New District
Shanghai, 201201
China
Private
developerabsorbable coronary drug-elute stentspecialized coronary drug-elute stent systemrapamycinracemic polylactic acidblood vesselinnovative and effective stent vessel systemmedical practitioner
* We use standard office opening hours in near Bioheart Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bioheart Biotechnology is Biotechnology business from China that founded in 2014 (10 years old in 2024), Bioheart Biotechnology business is focusing on Polylactic Acid.
Bioheart Biotechnology headquarter office and corporate office address is located in Room 302, 3/F, Building 9 590 Ruiqing Avenue, Zhangjiang High-Tech East Zone, Pudong New District Shanghai, 201201 China.
Bioheart Biotechnology was founded in China.
In 2024, Bioheart Biotechnology is currently focus on polylactic acid sector.
Above is snippet of Google Trends for "polylactic acid" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bioheart Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
